A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...
The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
These devices could serve as valuable tools for biomedical research and may have potential for clinical applications in the ...
Deep Brain Stimulation (DBS) involves implanting electrodes in specific areas of the brain that deliver electrical pulses to help regulate abnormal brain activity. This can alleviate symptoms such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback